EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results